Have a feature idea you'd love to see implemented? Let us know!

PODD Insulet Corp

Price (delayed)

$266.57

Market cap

$18.7B

P/E Ratio

44.28

Dividend/share

N/A

EPS

$6.02

Enterprise value

$19.19B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2662.1 and 11% lower than its last 4 quarters average of 49.7
The equity has soared by 84% YoY and by 12% QoQ

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
70.14M
Market cap
$18.7B
Enterprise value
$19.19B
Valuations
Price to book (P/B)
16.72
Price to sales (P/S)
9.42
EV/EBIT
56.89
EV/EBITDA
46.2
EV/Sales
9.67
Earnings
Revenue
$1.98B
Gross profit
$1.38B
Net income
$420.9M
EBIT
$337.4M
EBITDA
$415.5M
Free cash flow
$193.1M
Per share
EPS
$6.02
EPS diluted
$5.87
Free cash flow per share
$2.75
Book value per share
$15.95
Revenue per share
$28.29
TBVPS
$40.99
Balance sheet
Total assets
$3.03B
Total liabilities
$1.91B
Debt
$1.4B
Equity
$1.12B
Working capital
$1.35B
Liquidity
Debt to equity
1.25
Current ratio
3.68
Quick ratio
2.53
Net debt/EBITDA
1.19
Margins
EBITDA margin
20.9%
Gross margin
69.4%
Net margin
21.2%
Operating margin
15.4%
Efficiency
Return on assets
15.1%
Return on equity
46.3%
Return on invested capital
12.2%
Return on capital employed
13.4%
Return on sales
17%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
3.9%
1 week
-1.03%
1 month
0%
1 year
28.18%
YTD
22.85%
QTD
14.53%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.98B
Gross profit
$1.38B
Operating income
$306M
Net income
$420.9M
Gross margin
69.4%
Net margin
21.2%
The company's net margin has surged by 175% YoY
Insulet's operating income has surged by 123% YoY and by 12% QoQ
The company's operating margin has surged by 75% YoY and by 5% QoQ
PODD's gross profit is up by 35% YoY and by 6% from the previous quarter

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
P/E
44.28
P/B
16.72
P/S
9.42
EV/EBIT
56.89
EV/EBITDA
46.2
EV/Sales
9.67
PODD's price to earnings (P/E) is 98% lower than its 5-year quarterly average of 2662.1 and 11% lower than its last 4 quarters average of 49.7
The EPS has grown by 7% from the previous quarter
The equity has soared by 84% YoY and by 12% QoQ
PODD's price to book (P/B) is 61% less than its 5-year quarterly average of 42.7 but 3.2% more than its last 4 quarters average of 16.2
PODD's price to sales (P/S) is 32% lower than its 5-year quarterly average of 13.8 but 19% higher than its last 4 quarters average of 7.9
PODD's revenue is up by 27% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Insulet business performance
The return on assets has surged by 196% year-on-year
PODD's ROE has soared by 107% YoY but it is down by 8% QoQ
Insulet's return on invested capital has surged by 85% YoY and by 8% QoQ
The ROS has soared by 59% YoY and by 3.7% from the previous quarter

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 59% higher than the total liabilities
The total assets rose by 23% YoY and by 5% QoQ
Insulet's quick ratio has increased by 19% YoY and by 5% from the previous quarter
The company's debt is 25% higher than its equity
The equity has soared by 84% YoY and by 12% QoQ
The debt to equity has decreased by 47% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.